A. Horiuchi et al., DUAL ACTIONS OF GLUCAGON - DIRECT STIMULATION AND INDIRECT INHIBITIONOF DOG PANCREATIC-SECRETION, European journal of pharmacology, 237(1), 1993, pp. 23-30
The secretory actions of glucagon on the exocrine pancreas were examin
ed using two kinds of canine preparations. In the isolated and blood-p
erfused dog pancreas with venous drainage, i.a. injection of glucagon
did not inhibit secretin/cholecysto-kinin-octapeptide (CCK-8)-stimulat
ed pancreatic secretion, but instead dose dependently enhanced both ba
sal and stimulated pancreatic secretion. Glucagon-induced increase of
pancreatic secretion was potentiated by 3-isobutyl-1-methylxanthine. I
n contrast, iv. bolus injection of glucagon (3 and 10 nmol/kg) first a
ugmented transiently then suppressed secretin/CCK-8-stimulated pancrea
tic secretion while simultaneously increasing circulating plasma somat
ostatin immunoreactivity from 14.2 to 214 fmol/ml in anesthetized inta
ct dogs. The inhibition of secretin/CCK-8-stimulated pancreatic secret
ion and elevation of plasma somatostatin immunoreactivity induced by g
lucagon were comparable with those due to somatostatin-14. Thus, these
results indicate that glucagon stimulates pancreatic secretion direct
ly; the inhibitory action of glucagon is indirect and appears to be re
lated to a rise in the circulating level of somatostatin immunoreactiv
ity.